Multicenter, prospective, single-arm clinical study to investigate the efficacy and safety of Zoladex (Goserelin acetate) 10.8 mg prior to surgery in Chinese premenopausal women with symptomatic uterine fibroids
Objectives To assess the effect and safety of Zoladex (Goserelin acetate) 10.8 mg in patients with uterine fibroids.Methods Fifty-three patients received Goserelin acetate 10.8 mg once and surgery was conducted at 12 weeks ± 7 days after drug injection. All assessments form baseline to week12/before...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2024-12-01
|
| Col·lecció: | Gynecological Endocrinology |
| Matèries: | |
| Accés en línia: | https://www.tandfonline.com/doi/10.1080/09513590.2024.2427190 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|